(Q40035691)

English

Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors

scientific article published on October 2008

In more languages
default for all languages
No label defined

No description defined

Statements

Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors (English)
Johann S de Bono
Rebecca Kristeleit
Anthony Tolcher
Vasilios Karavasilis
Eric K Rowinsky
Jeffrey W Scott

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit